213 related articles for article (PubMed ID: 11278802)
1. Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences.
Ramanathan Y; Rajpara SM; Reza SM; Lees E; Shuman S; Mathews MB; Pe'ery T
J Biol Chem; 2001 Apr; 276(14):10913-20. PubMed ID: 11278802
[TBL] [Abstract][Full Text] [Related]
2. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
[TBL] [Abstract][Full Text] [Related]
3. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases.
Rickert P; Corden JL; Lees E
Oncogene; 1999 Jan; 18(4):1093-102. PubMed ID: 10023686
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs.
Guo Z; Stiller JW
BMC Genomics; 2004 Sep; 5():69. PubMed ID: 15380029
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II.
Napolitano G; Majello B; Licciardo P; Giordano A; Lania L
Gene; 2000 Aug; 254(1-2):139-45. PubMed ID: 10974544
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation.
Kim YK; Bourgeois CF; Isel C; Churcher MJ; Karn J
Mol Cell Biol; 2002 Jul; 22(13):4622-37. PubMed ID: 12052871
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.
Nekhai S; Zhou M; Fernandez A; Lane WS; Lamb NJ; Brady J; Kumar A
Biochem J; 2002 Jun; 364(Pt 3):649-57. PubMed ID: 12049628
[TBL] [Abstract][Full Text] [Related]
8. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
[TBL] [Abstract][Full Text] [Related]
9. Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II.
Pinhero R; Liaw P; Bertens K; Yankulov K
Eur J Biochem; 2004 Mar; 271(5):1004-14. PubMed ID: 15009212
[TBL] [Abstract][Full Text] [Related]
10. The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription.
Hoque M; Young TM; Lee CG; Serrero G; Mathews MB; Pe'ery T
Mol Cell Biol; 2003 Mar; 23(5):1688-702. PubMed ID: 12588988
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
Isel C; Karn J
J Mol Biol; 1999 Jul; 290(5):929-41. PubMed ID: 10438593
[TBL] [Abstract][Full Text] [Related]
12. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter.
Deng L; Ammosova T; Pumfery A; Kashanchi F; Nekhai S
J Biol Chem; 2002 Sep; 277(37):33922-9. PubMed ID: 12114499
[TBL] [Abstract][Full Text] [Related]
14. Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II.
Watanabe Y; Fujimoto H; Watanabe T; Maekawa T; Masutani C; Hanaoka F; Ohkuma Y
Genes Cells; 2000 May; 5(5):407-23. PubMed ID: 10886368
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
Devaiah BN; Singer DS
J Biol Chem; 2012 Nov; 287(46):38755-66. PubMed ID: 23027873
[TBL] [Abstract][Full Text] [Related]
16. Structural Motifs for CTD Kinase Specificity on RNA Polymerase II during Eukaryotic Transcription.
Ramani MKV; Escobar EE; Irani S; Mayfield JE; Moreno RY; Butalewicz JP; Cotham VC; Wu H; Tadros M; Brodbelt JS; Zhang YJ
ACS Chem Biol; 2020 Aug; 15(8):2259-2272. PubMed ID: 32568517
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation.
Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H
Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668
[TBL] [Abstract][Full Text] [Related]
18. Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II.
Lu H; Yu D; Hansen AS; Ganguly S; Liu R; Heckert A; Darzacq X; Zhou Q
Nature; 2018 Jun; 558(7709):318-323. PubMed ID: 29849146
[TBL] [Abstract][Full Text] [Related]
19. The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine.
Kaldis P; Cheng A; Solomon MJ
J Biol Chem; 2000 Oct; 275(42):32578-84. PubMed ID: 10931829
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
